Michelle Sanford in Mobile, Alabama

Home Alabama Mobile

Michelle Sanford has Nurse Practitioner as her primary medical specialty. Their primary office is: 3719 Dauphin St in Mobile, Alabama. There is an additional office location, for a total of two, for Michelle Sanford that can be viewed further down.

They're a part of the: Southern Cancer Center Pc medical group which has around 29 members. You can call their office at 251-625-6896 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of South Alabama College Of Medicine and graduated in 2013 (around 11 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michelle Sanford Office Phone and Directions

Michelle Sanford
Southern Cancer Center Pc
3719 Dauphin St
Mobile, Alabama 36608
251-625-6896

Patient Ratings
Please rate your experience with Michelle Sanford below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 251-625-6896

Enter a starting address:

Healthcare Info for Michelle Sanford

Medical School: University Of South Alabama College Of Medicine
Graduation Year: 2013
The Primary Medical Specialty for Michelle Sanford is listed as: Nurse Practitioner
Approximate Years of Experience: 11
PAC (PECOS ID)#: 8224260773
NPI #: 1487076873
NPI Created On: 01/20/2014
NPI Last Updated Listed as: 10/27/2021
Primary Taxonomy Code: 363LG0600X
License Number:
1-059045
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood test, comprehensive group of blood chemicals
Complete blood cell count (red cells, white blood cell, platelets), automated test
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301923

Being Disputed:: No

Product Related: No

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301925

Being Disputed:: No

Product Related: No

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301929

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301933

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301937

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788301941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Additional Office Locations

1. Southern Cancer Center Pc
3719 Dauphin St
Mobile, AL 36608
Suite 102
Group Members: 29

Phone: 251-625-6896

Enter a starting address:

Nurse Practitioner Professionals in Mobile

1.
Lindy Waller

3719 Dauphin St
Mobile, AL
Inpatient Consultants Of Alabama, Inc

2.
Haley Bishop

75 S University Blvd
Mobile, AL
Usa Health Physician Billing Services Llc

3.
Haley Bishop

2451 University Hospital Dr
Mobile, AL
Usa Health Physician Billing Services Llc

4.
Haley Bohannon

1700 Springhill Ave
Mobile, AL
Imc-diagnostic And Medical Clinic Llc

5.
Holly Horne

3280 Dauphin St
Mobile, AL
Coastal Neurological Institute Pc

6.
Laurie Vickery

3 Mobile Infirmary Circle
Mobile, AL
Imc-cancer Surgery Of Mobile, Llc

Providers in Southern Cancer Center Pc

1.Kimberly Aldis

201 Sivley Rd Sw
Huntsville Al 35801-5177
Southern Cancer Center Pc
Nurse Practitioner

2.Nicole Angel Md

29653 Anchor Cross Blvd
Daphne Al 36526-9594
Southern Cancer Center Pc
Medical Oncology

3.Nicole Angel Md

3719 Dauphin St
Mobile Al 36608-1753
Southern Cancer Center Pc
Medical Oncology

4.Nicole Angel Md

3719 Dauphin St
Mobile Al 36608-1769
Southern Cancer Center Pc
Medical Oncology

5.Nicole Angel Md

6701 Airport Blvd
Mobile Al 36608-6705
Southern Cancer Center Pc
Medical Oncology

6.Sherri Arledge

29653 Anchor Cross Blvd
Daphne Al 36526-9594
Southern Cancer Center Pc
Medical Oncology

View all 29 members of Southern Cancer Center Pc medical group